High level of risk for Arrowhead Pharmaceuticals with negati...
High level of risk for Arrowhead Pharmaceuticals with negative EBIT and a dip in free cash flow. The company burnt US$331m, reported a US$205m loss raising capital raising flags. Investors monitor balance sheet and warning signs needed.
Health Check: How Prudently Does Arrowhead Pharmaceuticals (NASDAQ:ARWR) Use Debt?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4557Followers
0Following
9961Visitors
Follow